Who else but Kreigscam would call 10/ 13 patients with stable disease or better "POWERFUL data". Clearly he's not a guy who knows statistics.
“We are excited to share the powerful data from our aldoxorubicin clinical trial with experts from the international oncology community at this preeminent sarcoma conference, ... ". Press release today.
Only Kreigsman would call 10 / 13 "powerful data" . Any legit CEO of a legit biotech would say something like "we are please that there appears to be a signal...". But Kreigscam is so desperate to keep scamming that every little potential positive news is treated like a miracle. He preys on unsuspecting newcomers to biotech investing. No investor with money will go near a used car salesman like this guy. After all these years, Kreigscam should be should have had this drug near approval with lots of momentum and high investigator interest. But no, he's a selfish scammer. Can you imagine if 50% of his compensation had been spent on improving the trials? He would have been much closer to the finish line. But no, he's a scamming con man that needs a "bird in the hand" (i.e. cash comp today) so he can impress his buddies and pretend to be a big biotech guys in California. Dr. Sant Chawla must be wondering why in the world he ever agreed to deal with this guy. All IMO of course.